vorinostat has been researched along with Coxsackie Virus Infections in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Excerpt | Relevance | Reference |
---|---|---|
"Viral myocarditis was eventually aggravated rather than ameliorated by HDAC inhibition." | 1.42 | Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis. ( Gao, B; He, X; Xiong, S; Zhou, L, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zhou, L | 1 |
He, X | 1 |
Gao, B | 1 |
Xiong, S | 1 |
1 other study available for vorinostat and Coxsackie Virus Infections
Article | Year |
---|---|
Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
Topics: Androstadienes; Animals; Antiviral Agents; Apoptosis; Autophagy-Related Protein 5; Coxsackievirus In | 2015 |